NATIONAL INSTITUTES OF HEALTH has floated a tender for Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional). The project location is USA and the tender is closing on 07 May 2023. The tender notice number is PAR-19-282, while the TOT Ref Number is 33014618.
Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : USA
Summary : Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
Deadline : 07 May 2023
Other Information
Notice Type : Tender
TOT Ref.No.: 33014618
Document Ref. No. : PAR-19-282
Competition : ICB
Financier : Self Financed
Purchaser Ownership : -
Tender Value : Refer Document
Purchaser's Detail
Purchaser : NATIONAL INSTITUTES OF HEALTH NIH OER WebmasterFBOWebmaster@OD.NIH.GOV USA Email :FBOWebmaster@OD.NIH.GOV
Tender Details
Tender are invited for Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
CFDA Number : 93.279 -- Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement : No
Closing Date for Applications: May 07, 2023
Posted Date : May 15, 2019
Description: This Funding Opportunity Announcement (FOA) uses a R61/R33 Phased Innovation Award mechanism to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying SUD, including fundamental brain function relevant to substance use. This FOA is particularly designed to support exploratory/developmental projects requiring budgets that would exceed that allowed for the R21 mechanism (Neuroscience Research on Drug Abuse (R21 Clinical Trial Optional)